Compare with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES PANACEA BIOTECH ALKEM LABORATORIES/
PANACEA BIOTECH
 
P/E (TTM) x - 11.7 - View Chart
P/BV x 6.5 2.8 232.5% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 ALKEM LABORATORIES   PANACEA BIOTECH
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
PANACEA BIOTECH
Mar-18
ALKEM LABORATORIES/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,589364 436.5%   
Low Rs1,232129 954.3%   
Sales per share (Unadj.) Rs417.596.8 431.3%  
Earnings per share (Unadj.) Rs56.3-12.4 -453.7%  
Cash flow per share (Unadj.) Rs64.7-2.9 -2,268.6%  
Dividends per share (Unadj.) Rs12.700-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs292.950.4 581.2%  
Shares outstanding (eoy) m119.5761.25 195.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.42.5 132.6%   
Avg P/E ratio x25.1-19.9 -126.1%  
P/CF ratio (eoy) x21.8-86.4 -25.2%  
Price / Book Value ratio x4.84.9 98.4%  
Dividend payout %22.60-   
Avg Mkt Cap Rs m168,65315,101 1,116.8%   
No. of employees `000NA2.5 0.0%   
Total wages/salary Rs m9,1711,516 605.0%   
Avg. sales/employee Rs ThNM2,401.9-  
Avg. wages/employee Rs ThNM614.2-  
Avg. net profit/employee Rs ThNM-307.9-  
INCOME DATA
Net Sales Rs m49,9155,928 842.0%  
Other income Rs m1,64582 1,998.9%   
Total revenues Rs m51,5616,010 857.9%   
Gross profit Rs m8,482845 1,003.5%  
Depreciation Rs m1,006585 171.8%   
Interest Rs m6711,006 66.7%   
Profit before tax Rs m8,451-664 -1,273.7%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m02 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,60699 1,628.8%   
Profit after tax Rs m6,731-760 -885.7%  
Gross profit margin %17.014.3 119.2%  
Effective tax rate %19.0-14.9 -127.9%   
Net profit margin %13.5-12.8 -105.2%  
BALANCE SHEET DATA
Current assets Rs m27,0625,603 482.9%   
Current liabilities Rs m15,3246,910 221.8%   
Net working cap to sales %23.5-22.0 -106.7%  
Current ratio x1.80.8 217.8%  
Inventory Days Days67206 32.3%  
Debtors Days Days4184 49.3%  
Net fixed assets Rs m12,6109,941 126.8%   
Share capital Rs m23961 390.0%   
"Free" reserves Rs m34,4903,026 1,139.9%   
Net worth Rs m35,0273,087 1,134.7%   
Long term debt Rs m1,2125,707 21.2%   
Total assets Rs m54,38716,076 338.3%  
Interest coverage x13.60.3 3,996.8%   
Debt to equity ratio x01.8 1.9%  
Sales to assets ratio x0.90.4 248.9%   
Return on assets %13.61.5 890.1%  
Return on equity %19.2-24.6 -78.1%  
Return on capital %24.93.9 634.7%  
Exports to sales %12.924.0 53.9%   
Imports to sales %3.117.5 17.6%   
Exports (fob) Rs m6,4611,424 453.6%   
Imports (cif) Rs m1,5401,040 148.1%   
Fx inflow Rs m6,5631,600 410.2%   
Fx outflow Rs m3,0121,131 266.2%   
Net fx Rs m3,552469 757.9%   
CASH FLOW
From Operations Rs m7,2591,180 615.0%  
From Investments Rs m1,864553 337.2%  
From Financial Activity Rs m-9,273-1,644 564.2%  
Net Cashflow Rs m-15090 -167.2%  

Share Holding

Indian Promoters % 66.9 74.5 89.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 0.6 5,516.7%  
FIIs % 0.0 1.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 23.6 -  
Shareholders   68,381 10,259 666.5%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SANOFI INDIA  TORRENT PHARMA  TTK HEALTHCARE  JUBILANT LIFE SCIENCES  BIOCON   

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum, Key Q2FY20 Results, and Top Cues in Focus Today(Pre-Open)

On Wednesday, Indian share markets traded on a volatile note throughout the day and ended marginally higher.

Related Views on News

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (4QFY18); Net Profit Down 66.5% (Quarterly Result Update)

Jun 20, 2018 | Updated on Jun 20, 2018

For the quarter ended March 2018, PANACEA BIOTECH has posted a net profit of Rs 86 m (down 66.5% YoY). Sales on the other hand came in at Rs 2 bn (up 0.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Oct 16, 2019 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS